BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10979309)

  • 1. [[The role of TNF-alpha in myelodysplastic syndrome: immunoserologic and immunohistochemical studies] ].
    Molnár L; Berki T; Hussain A; Németh P; Losonczy H
    Orv Hetil; 2000 Aug; 141(33):1807-11. PubMed ID: 10979309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY; Li X; Chang CK; Ying SX; Pu Q
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of TNFalpha expression in the bone marrow and determination of TNFalpha production of peripheral blood mononuclear cells in myelodysplastic syndrome.
    Molnár L; Berki T; Hussain A; Németh P; Losonczy H
    Pathol Oncol Res; 2000; 6(1):18-23. PubMed ID: 10749583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
    Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A
    Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum TNF-alpha concentrations are predictive of shortened survival in patients with high-risk myelodysplastic syndromes.
    Alexandrakis M; Coulocheri S; Xylouri I; Ganotakis E; Eliakis P; Karkavitsas N; Eliopoulos GD
    Haematologia (Budap); 1998; 29(1):13-24. PubMed ID: 9704253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS).
    Economopoulou C; Pappa V; Papageorgiou S; Kontsioti F; Economopoulou P; Charitidou E; Girkas K; Kapsimali V; Papasteriadi C; Tsirigotis P; Papageorgiou E; Dervenoulas J; Economopoulos T
    Ann Hematol; 2010 Apr; 89(4):349-58. PubMed ID: 19813013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.
    Wu L; Li X; Chang C; Ying S; He Q; Pu Q
    Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
    Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cA2 anti-tumor necrosis factor-alpha antibody therapy on hematopoiesis of patients with myelodysplastic syndromes.
    Boula A; Voulgarelis M; Giannouli S; Katrinakis G; Psyllaki M; Pontikoglou C; Markidou F; Eliopoulos GD; Papadaki HA
    Clin Cancer Res; 2006 May; 12(10):3099-108. PubMed ID: 16707608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
    Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
    Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase inhibitor reduces apoptosis induction of bone marrow cells in MDS-RA.
    Arimura K; Arima N; Matsushita K; Ohtsubo H; Fujiwara H; Kukita T; Ozaki A; Hagiwara T; Hamada H; Yoshino K; Tei C
    Eur J Haematol; 2004 Jul; 73(1):17-24. PubMed ID: 15182333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
    Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
    Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab chimaeric anti-tumour necrosis factor alpha monoclonal antibody treatment for patients with myelodysplastic syndromes.
    Stasi R; Amadori S
    Br J Haematol; 2002 Feb; 116(2):334-7. PubMed ID: 11841434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective tumor necrosis factor alpha-induced maturation of monocyte-derived dendritic cells in patients with myelodysplastic syndromes.
    Micheva I; Thanopoulou E; Michalopoulou S; Karakantza M; Kouraklis-Symeonidis A; Mouzaki A; Zoumbos N
    Clin Immunol; 2004 Dec; 113(3):310-7. PubMed ID: 15507396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
    Keith T; Araki Y; Ohyagi M; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Kitagawa M
    Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice.
    Capocasale RJ; Makropoulos DA; Achuthanandam R; Stowell N; Quinn J; Rafferty PA; O'Brien J; Emmell E; Bugelski PJ
    Cytometry A; 2008 Feb; 73(2):148-59. PubMed ID: 18205195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transcriptome profiling of marrow mononuclear cells of patients with myelodysplastic syndrome using cDNA microarray analysis].
    Qian J; Chen ZX; Wang W; Cen JN; Xue YQ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1260-4. PubMed ID: 15387962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.